Phs. II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients W/Advanced Stage or Inoperable Non-Small Cell Lung Cancer (NSCLC)

This study has suspended participant recruitment.
Sponsor:
Collaborator:
Genentech
Information provided by:
Montefiore Medical Center
ClinicalTrials.gov Identifier:
NCT00200395
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given